Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01836276 · ClinicalTrials.gov registry record · Phase 4
Understanding Disparities in Quitting in African American and White Smokers
A Phase 4 study, sponsored by Nikki Nollen, PhD, MA.
- Completed
- Registry status
- Phase 4
- Development phase
- 449
- Enrollment target
NCT01836276 is a Phase 4 study that has completed, run by Nikki Nollen, PhD, MA. The registered enrollment target is 449 participants.
The verdict
NCT01836276, a Phase 4 study, has completed, sponsored by Nikki Nollen, PhD, MA.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 449 participants
- Enrollment target
Study Summary
The purpose of this study is to describe the differences in quitting smoking between African Americans (AA) and White smokers treated with varenicline.
Interventions
- DRUG Varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 449 participants |
| Start Date | 2013-02 |
| Est. Completion | 2017-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01836276
The ClinicalTrials.gov registry entry for NCT01836276 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 449 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nikki Nollen, PhD, MA, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Varenicline is the first listed.
NCT01836276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01836276 about?
NCT01836276 is a clinical study titled "Understanding Disparities in Quitting in African American and White Smokers". The purpose of this study is to describe the differences in quitting smoking between African Americans (AA) and White smokers treated with varenicline.
What is the current status of trial NCT01836276?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 449 participants. The study started on 2013-02. Estimated completion is 2017-04.
What interventions are being tested in trial NCT01836276?
The interventions under investigation include: Varenicline (DRUG).
Who is sponsoring clinical trial NCT01836276?
This trial is sponsored by Nikki Nollen, PhD, MA, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.